![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, March 29, 2013 3:11:31 PM
Came across this article on ANAC:
http://www.marketwatch.com/story/3-stock-picks-from-the-next-david-einhorn-2013-03-29?pagenumber=2
Michael Castor also summarized his investment thesis in another small-cap stock in his February investor letter: Anacor Pharmaceuticals ANAC -0.62% . He talked about the stock because it lost 12.5% of its value in February, but Castor said he is long-term bullish about the stock. Here is what he said:
"We had only one notable loser in the portfolio in February, Anacor Pharmaceuticals. This is an interesting little company that we like for the long term. We foresee four ways to win with our investment in Anacor.
“First, Anacor has a drug to treat toenail fungus. This product has successfully completed two late-stage clinical trials. It is safe and effective.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM